News
Hain Celestial drives growth with a better-for-you food strategy, streamlined brands, GLP-1-friendly innovation and more.
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback